HIV/AIDS
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: HIV infected ARV naïve adults Between 18 to 44 years of age CD4+ count of >350 cells/mm3
Exclusion criteria
Exclusion criteria: Pregnant/lactating women Hepatic/renal insufficiency Chronic disease eg cancer, diabetes, cardiac Taking antibiotics for up to 1 month before beginning the trial Under 18 years and over 44 years Postmenopausal women CD4 counts <350 cells/mm3 Taking ARV/HAART Consuming dietary supplements with either pre or probiotics for up to 1 month before beginning the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare changes in microbial translocation by detecting changes in the concentrations of both lipopolysaccharide (LPS) and soluble CD14 (sCD14) in participants in the inulin-type fructans versus placebo group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the incidence of diarrhoea and in quality of life;Changes in anthropometry and fat free mass | — |
Countries
South Africa
Contacts
University of KwaZulu Natal